Carbon monoxide ameliorates renal cold ischemia-reperfusion injury with an upregulation of vascular endothelial growth factor by activation of hypoxia-inducible factor

Transplantation

Volumn 85, Issue 12, 2008, Pages 1833-1840

  Faleo, Gaetano ^a,b   Neto, Joao Seda ^a   Kohmoto, Junichi ^a   Tomiyama, Koji ^a   Shimizu, Hiroko ^c   Takahashi, Toru ^c   Wang, Yinna ^a   Sugimoto, Ryujiro ^a   Choi, Augustine M K ^d   Stolz, Donna B ^d   Carrieri, Giuseppe ^b   McCurry, Kenneth R ^a   Murase, Noriko ^a   Nakao, Atsunori ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b UNIVERSITY OF FOGGIA   (Italy)

^c OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

^d UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Carbon monoxide; Hypoxia inducible factor; Ischemia reperfusion injury; Renal transplantation; Vascular endothelial growth factor

Indexed keywords

1 BENZYL 3 (5 HYDROXYMETHYL 2 FURYL)INDAZOLE; CARBON MONOXIDE; CARBOXYHEMOGLOBIN; EARLY GROWTH RESPONSE FACTOR 1; ENDOTHELIN 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; NITRIC OXIDE; UNIVERSITY OF WISCONSIN SOLUTION; VASCULOTROPIN; ENDOTHELIN RECEPTOR; HIF1A PROTEIN, RAT; MESSENGER RNA; PLASMINOGEN ACTIVATOR INHIBITOR 1; VASCULOTROPIN A;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; COLD ISCHEMIA; CONTROLLED STUDY; HYPOXEMIA; KIDNEY FUNCTION; KIDNEY ISCHEMIA; KIDNEY TRANSPLANTATION; KIDNEY TUBULE CELL; MALE; NONHUMAN; ORTHOTOPIC TRANSPLANTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; RENAL GRAFT DYSFUNCTION; RENAL PROTECTION; REPERFUSION INJURY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; VASCULAR ENDOTHELIUM; WESTERN BLOTTING; ANIMAL; DOSE RESPONSE; DRUG EFFECT; GENETICS; INHALATIONAL DRUG ADMINISTRATION; KIDNEY; LEWIS RAT; METABOLISM; METHODOLOGY; PHYSIOLOGY;

ADMINISTRATION, INHALATION; ANIMALS; CARBON MONOXIDE; COLD ISCHEMIA; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIN-1; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; KIDNEY; KIDNEY TRANSPLANTATION; MALE; NITRIC OXIDE; PLASMINOGEN ACTIVATOR INHIBITOR 1; RATS; RATS, INBRED LEW; RECEPTORS, ENDOTHELIN; REPERFUSION INJURY; RNA, MESSENGER; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 49149130917     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e31817c6f63     Document Type: Article

References (46)

1. Tullius SG, Heemann U, Hancock WW, et al. Long-term kidney isografts develop functional and morphologic changes that mimic those of chronic allograft rejection. Ann Surg 1994; 220: 425.
2. Gueler F, Gwinner W, Schwarz A, et al. Long-term effects of acute ischemia and reperfusion injury. Kidney Int 2004; 66: 523.
3. Otterbein LE. Carbon monoxide: Innovative anti-inflammatory properties of an age-old gas molecule. Antioxid Redox Signal 2002; 4: 309.
4. Neto JS, Nakao A, Kimizuka K, et al. Protection of transplant-induced renal ischemia-reperfusion injury with carbon monoxide. Am J Physiol Renal Physiol 2004; 287: F979.
5. Nakao A, Kimizuka K, Stolz DB, et al. Carbon monoxide inhalation protects rat intestinal grafts from ischemia/reperfusion injury. Am J Pathol 2003; 163: 1587.
6. Forsythe JA, Jiang BH, Iyer NV, et al. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol 1996; 16: 4604.
7. Ferrara N. Role of vascular endothelial growth factor in the regulation of angiogenesis. Kidney Int 1999; 56: 794.
8. Leung DW, Cachianes G, Kuang WJ, et al. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 1989; 246: 1306.
9. Jozkowicz A, Huk I, Nigisch A, et al. Heme oxygenase and angiogenic activity of endothelial cells: Stimulation by carbon monoxide and inhibition by tin protoporphyrin-IX. Antioxid Redox Signal 2003; 5: 155.
10. Li Volti G, Sacerdoti D, Sangras B, et al. Carbon monoxide signaling in promoting angiogenesis in human microvessel endothelial cells. Antioxid Redox Signal 2005; 7: 704.
11. Bacon AL, Harris AL. Hypoxia-inducible factors and hypoxic cell death in tumour physiology. Ann Med 2004; 36: 530.
12. Chin BY, Jiang G, Wegiel B, et al. Hypoxia-inducible factor 1alpha stabilization by carbon monoxide results in cytoprotective preconditioning. Proc Natl Acad Sci USA 2007; 104: 5109.
13. Fisher BLS. Microvascular surgical techniques in research, with special reference to renal transplantation in the rat. Surgery 1965; 58: 904.
14. Sunderman FW Jr, Downs JR, Reid MC, et al. Gaschromatographic assay for heme oxygenase activity. Clin Chem 1982; 28: 2026.
15. Nakao A, Toyokawa H, Tsung A, et al. Ex vivo application of carbon monoxide in university of wisconsin solution to prevent intestinal cold ischemia/reperfusion injury. Am J Transplant 2006; 6:2243.
16. Nakao A, Neto JS, Kanno S, et al. Protection against ischemia/reperfusion injury incardiac and renal transplantation with carbon monoxide, biliverdin and both. Am J Transplant 2005; 5: 282.
17. Tuder RM, Flook BE, Voelkel NF. Increased gene expression for VEGF and the VEGF receptors KDR/Flk and Flt in lungs exposed to acute or to chronic hypoxia. Modulation of gene expression by nitric oxide. J Clin Invest 1995; 95: 1798.
18. Heyman SN, Brezis M, Epstein FH, et al. Effect of glycine and hypertrophy on renal outer medullary hypoxic injury in ischemia reflow and contrast nephropathy. Am J Kidney Dis 1992; 19: 578.
19. Yan SF, Fujita T, Lu J, et al. Egr-1, a master switch coordinating up-regulation of divergent gene families underlying ischemic stress. Nat Med 2000; 6: 1355.
20. Shin DH, Kim JH, Jung YJ, et al. Preclinical evaluation of YC-1, a HIF inhibitor, for the prevention of tumor spreading. Cancer Lett 2007; 255: 107.
21. Yeo EJ, Chun YS, Cho YS, et al. YC-1: A potential anticancer drug targeting hypoxia-inducible factor 1. J Natl Cancer Inst 2003; 95: 516.
22. Miyamoto K, Kitamoto Y, Tokunaga H, et al. Protective effect of vascular endothelial growth factor/vascular permeability factor 165 and 121 on glomerular endothelial cell injury in the rat. Lab Invest 2004; 84: 1126.
23. Schrijvers BF, Flyvbjerg A, de Vriese AS. The role of vascular endothelial growth factor (VEGF) in renal pathophysiology. Kidney Int 2004; 65: 2003.
24. Kang DH, Kanellis J, Hugo C, et al. Role of the microvascular endothelium in progressive renal disease. J Am Soc Nephrol 2002; 13:806.
25. Luo Z, Diaco M, Murohara T, et al. Vascular endothelial growth factor attenuates myocardial ischemia-reperfusion injury. Ann Thorac Surg 1997; 64: 993.
26. Tsurui Y, Sho M, Kuzumoto Y, et al. Dual role of vascular endothelial growth factor in hepatic ischemia-reperfusion injury. Transplantation 2005; 79: 1110.
27. Takeshita S, Pu LQ, Stein LA, et al. Intramuscular administration of vascular endothelial growth factor induces dose-dependent collateral artery augmentation in a rabbit model of chronic limb ischemia. Circulation 1994; 90(5 Pt 2): II228.
28. Addya S, Shiroto K, Turoczi T, et al. Ischemic preconditioning-mediated cardioprotection is disrupted in heterozygous Flt-1 (VEGFR-1) knockout mice. J Mol Cell Cardiol 2005; 38: 345.
29. van der Zee R, Murohara T, Luo Z, et al. Vascular endothelial growth factor/vascular permeability factor augments nitric oxide release from quiescent rabbit and human vascular endothelium. Circulation 1997; 95: 1030.
30. Ziche M, Morbidelli L, Choudhuri R, et al. Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis. J Clin Invest 1997; 99: 2625.
31. Kanellis J, Fraser S, Katerelos M, et al. Vascular endothelial growth factor is a survival factor for renal tubular epithelial cells. Am J Physiol Renal Physiol 2000; 278: F905.
32. Villegas G, Lange-Sperandio B, Tufro A. Autocrine and paracrine functions of vascular endothelial growth factor (VEGF) in renal tubular epithelial cells. Kidney Int 2005; 67: 449.
33. Alvarez Arroyo MV, Suzuki Y, Yague S, et al. Role of endogenous vascular endothelial growth factor in tubular cell protection against acute cyclosporine toxicity. Transplantation 2002; 74: 1618.
34. Reinders ME, Sho M, Izawa A, et al. Proinflammatory functions of vascular endothelial growth factor in alloimmunity. J Clin Invest 2003; 112: 1655.
35. Boros P, Tarcsafalvi A, Wang L, et al. Intrahepatic expression and release of vascular endothelial growth factor following orthotopic liver transplantation in the rat. Transplantation 2001; 72: 805.
36. Tsuchihashi S, Ke B, Kaldas F, et al. Vascular endothelial growth factor antagonist modulates leukocyte trafficking and protects mouse livers against ischemia/reperfusion injury. Am J Pathol 2006; 168: 695.
37. von Dobschuetz E, Meyer S, Thorn D, et al. Targeting vascular endothelial growth factor pathway offers new possibilities to counteract microvascular disturbances during ischemia/reperfusion of the pancreas. Transplantation 2006; 82: 543.
38. Neufeld G, Cohen T, Gengrinovitch S, et al. Vascular endothelial growth factor (VEGF) and its receptors. Faseb J 1999; 13: 9.
39. Semenza GL. Targeting HIF-1 for cancer therapy. Nat Rev Cancer2003; 3: 721.
40. Herrero I, Torras J, Riera M, et al. Prevention of cold ischaemia-reperfusion injury by an endothelin receptor antagonist in experimental renal transplantation. Nephrol Dial Transplant 1999; 14: 872.
41. Szabo G, Fazekas L, Bahrle S, et al. Endothelin-A and -B antagonists protect myocardial and endothelial function after ischemia/reperfusion in a rat heart transplantation model. Cardiovasc Res 1998; 39: 683.
42. Stanford SJ, Walters MJ, Mitchell JA. Carbon monoxide inhibits endothelin-1 release by human pulmonary artery smooth muscle cells. Eur J Pharmacol 2004; 486: 349.
43. Lee BS, Heo J, Kim YM, et al. Carbon monoxide mediates heme oxygenase 1 induction via Nrf2 activation in hepatoma cells. Biochem Biophys Res Commun 2006; 343: 965.
44. Sawle P, Foresti R, Mann BE, et al. Carbon monoxide-releasing molecules (CO-RMs) attenuate the inflammatory response elicited by lipopolysaccharide in RAW264.7 murine macrophages. Br J Pharmacol 2005; 145: 800.
45. Hegazi RA, Rao KN, Mayle A, et al. Carbon monoxide ameliorates chronic murine colitis through a heme oxygenase 1-dependent pathway. J Exp Med 2005; 202: 1703.
46. Zhang X, Shan P, Alam J, et al. Carbon monoxide modulates Fas/Fas ligand, caspases, and Bcl-2 family proteins via the p38alpha mitogen-activated protein kinase pathway during ischemia-reperfusion lung injury. J Biol Chem 2003; 278: 22061.